Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay - Wikidata - wikimedia - TriplyDB

Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay

Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay

http://www.wikidata.org/entity/Q28476138

about

Antifungal testing and high-throughput screening of compound library against Geomyces destructans, the etiologic agent of geomycosis (WNS) in bats Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin α1-antitrypsin Z A High-Throughput Small Molecule Screen for C. elegans Linker Cell Death Inhibitors Antifungal activity of microbial secondary metabolites Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile Targeting the adaptability of heterogeneous aneuploids Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis Caenorhabditis elegans-based model systems for antifungal drug discovery.Wild-type Drosophila melanogaster as an alternative model system for investigating the pathogenicity of Candida albicans.Using C. elegans for antimicrobial drug discovery.A screening assay based on host-pathogen interaction models identifies a set of novel antifungal benzimidazole derivatives.Quantitative and automated high-throughput genome-wide RNAi screens in C. elegans.Characterization of plant-derived saponin natural products against Candida albicans.The anti-mitochondrial antifungal assay for the discovery and development of new drugs.In vitro analysis of finasteride activity against Candida albicans urinary biofilm formation and filamentation.Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production High-throughput nano-biofilm microarray for antifungal drug discovery Effect of tetrandrine against Candida albicans biofilms Discovery of potential anti-infectives against Staphylococcus aureus using a Caenorhabditis elegans infection model.Candida albicans VPS4 contributes differentially to epithelial and mucosal pathogenesis.Chemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis.The role of mycelium production and a MAPK-mediated immune response in the C. elegans-Fusarium model system C. elegans: model host and tool for antimicrobial drug discovery.Caenorhabditis elegans, a model organism for investigating immunity.Whole animal HTS of small molecules for antifungal compounds.Activity of caffeic acid phenethyl ester in Caenorhabditis elegans.Strategies in the discovery of novel antifungal scaffolds.An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs.A living model for obesity and aging research: Caenorhabditis elegans.Exploring the diversity and metabolic potential of actinomycetes from temperate marine sediments from Newfoundland, Canada.Thymol has antifungal activity against Candida albicans during infection and maintains the innate immune response required for function of the p38 MAPK signaling pathway in Caenorhabditis elegans.Interaction of Staphylococcus aureus persister cells with the host when in a persister state and following awakening.Natural product solasodine-3-O-β-D-glucopyranoside inhibits the virulence factors of Candida albicans.Alkyl Protocatechuate-Loaded Nanostructured Lipid Systems as a Treatment Strategy for Paracoccidioides brasiliensis and Paracoccidioides lutzii In Vitro Models to study ancient host-pathogen interactions: lessons from Crete.Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata.Activity of gallic acid and its ester derivatives in Caenorhabditis elegans and zebrafish (Danio rerio) models.Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.Promising Antifungal Targets Against Based on Ion Homeostasis Exophiala dermatitidis isolates from various sources: using alternative invertebrate host organisms (Caenorhabditis elegans and Galleria mellonella) to determine virulence

P2860

Q21560851-8D4F2DD4-CF5E-49AA-9114-3D0FEB410C27 Q21562132-27DCA455-BA65-4852-8FAA-31C3BA8238EA Q27320254-6B12834A-0A51-4F06-A09B-821E8E96463E Q28477201-89EE024C-C8C5-4D4B-860A-CC81528AD58B Q28489096-0479BBDE-A7F5-4E7D-BD2C-93A5D3C5E1CD Q28649939-9B7F0D6D-0DAB-4329-81BF-D8B8B936FFEB Q28818603-92BAC35C-2705-496E-A0A1-6348BB7B791D Q33864072-97A4B712-9363-4DE7-988A-5DD66FBD7CBF Q33888842-F3C95F86-CE3B-4A02-9B9A-EF0F84DEF6C7 Q33936475-1D87B10A-3B56-47EA-96AC-013EBF45E2A7 Q33957538-6CF761C3-D75E-4BBE-99B2-830B1555EB6B Q34186716-0CB860A3-A51F-4580-918F-2BD22512A2DB Q34248026-D33349AC-BD2E-4B1A-BC57-1CAC76B5F2B3 Q34278041-3DE45079-F5A5-4027-A041-0D987D07FE9A Q34298898-B3C72E98-997F-4B7A-A041-18FF6DF15336 Q34358699-A47FF787-5A0E-46F3-8E8A-5AC75240B3BA Q34783867-2779ABFB-AB8A-48A9-95DA-447D65A659FA Q35048626-88B32643-3B09-4162-A8F1-04381061982B Q35083772-7BE2B2B5-D30F-4604-BEFD-8AD4222B839C Q36147101-B2DBFB4A-B74E-4F31-AB40-B8E6E9D80818 Q37104113-C2326FE4-DB60-4268-BA79-52B33C72DB60 Q37139366-868EFB94-9E32-4E55-8BAF-7E5051D9CEFA Q37866903-B309033A-4D38-4A91-B467-1532CD200D89 Q37979713-14A4577F-97BF-4344-B2EE-E4662DCCB59A Q38642986-C83D8F3E-668D-4A9B-9EC8-CA363588D875 Q38811816-C4CFB7A4-FFBB-4BB6-B0A4-B45EB63BE4AD Q38837363-79DFBC63-154E-4FD8-9420-9770FCEA3B2B Q38840796-098AB672-7594-474D-A7C2-756E4AEFF69E Q38941115-B3EB642B-F1BC-4AA8-8079-0D40FC8BD5CF Q38942619-0088742D-0E7B-4DFC-806D-B75A88AF3385 Q40091006-17C2FA7C-6495-4852-A2FE-37089AC5465D Q40582476-21451672-85E1-4AA6-8010-708DDF437A9C Q41114202-6E64C640-12CF-43CE-B987-1A92302113D7 Q41940101-C3981787-967B-405E-AE00-F2903B482D8D Q42576216-1A989744-A826-4B91-8244-95DC3BD06CC3 Q47127950-C05A23A7-BA2D-47D2-8CE1-EB1F2DFC72A3 Q47549081-8533ACC3-8D51-4112-B931-090C9935570A Q55511181-17AE4CBD-E1E2-4BF6-98EA-07CE4535E6FD Q57161198-48A520B0-17C4-48C3-8884-CBDCDD555D0D Q57167694-677B251D-80B1-4E71-8CB1-36EA6F5AA292

P2860

Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay

http://www.wikidata.org/entity/Q28476138

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Identification of antifungal c ...... t Caenorhabditis elegans assay

@ast

Identification of antifungal c ...... t Caenorhabditis elegans assay

@en

Identification of antifungal c ...... t Caenorhabditis elegans assay

@nl

type

label

Identification of antifungal c ...... t Caenorhabditis elegans assay

@ast

Identification of antifungal c ...... t Caenorhabditis elegans assay

@en

Identification of antifungal c ...... t Caenorhabditis elegans assay

@nl

prefLabel

Identification of antifungal c ...... t Caenorhabditis elegans assay

@ast

Identification of antifungal c ...... t Caenorhabditis elegans assay

@en

Identification of antifungal c ...... t Caenorhabditis elegans assay

@nl

P1433

Q28476138-4267C74F-EC72-433A-A756-5E832F25B290

P1476

Q28476138-986FD494-7DFA-436D-8EDF-CFC952175516

P2093

Q28476138-0CC744E1-33C6-4D87-949C-5F9AE68343FD

Q28476138-286FD159-5B07-413B-84CE-76D9D40462E9

Q28476138-3DC4C831-170C-4E43-A784-083337EDDB8A

Q28476138-484E311F-8F6C-4ED1-B4EE-E6101198B8D5

Q28476138-90EC44D2-CD09-4FB5-8684-F58FF2E9BDE7

Q28476138-A5157E6B-9BBD-49DD-B66C-BBDC7970F335

Q28476138-C011CE95-CCAC-411C-9990-98F477B1510C

Q28476138-CD5EB0B1-3832-45C8-8840-47932C38FFA5

Q28476138-EB8423FA-6F30-47DD-A675-89FB7E0404B6

Q28476138-FDF2588D-FFFB-49E3-9FFA-0583B3CC79B8

P2860

Q28476138-00D06D31-B452-4121-9C1E-D7434FFC0271

Q28476138-032C167F-B42B-41DF-9CBC-BB5F36AB2590

Q28476138-03B7EBC6-1899-4D4D-86CC-9EA14CAEBADC

Q28476138-0584299E-06B5-4612-94E2-2B8B5CBDCF62

Q28476138-0799A99E-6495-41DF-BFCE-F27FEA56ADA4

Q28476138-087C3602-F317-44D4-86FC-0153EC436698

Q28476138-12259D70-7A01-475B-852F-D89741E912C8

Q28476138-1266B2AA-6AC9-4F91-A555-7842E63497F6

Q28476138-16934723-D201-4CFF-AE3D-E7087F695AED

Q28476138-16D985D8-B020-4E2F-A532-191786C8B809

P304

Q28476138-5E2471AF-D154-4A98-A63C-C0E6DBA763BF

P31

Q28476138-CE80EBAF-E7F1-4B2A-919D-4BFC5C9326BF

P3181

Q28476138-B972B947-C92A-4A43-A30F-51295CF427D8

P356

Q28476138-C0918F6C-A5DF-49D6-817A-37CB35A439BA

P407

Q28476138-089A1070-D8C0-4F2C-A1A1-8ED4E2C6FDC8

P433

Q28476138-E46F3FBF-4607-4EB8-9866-43B3C781918B

P478

Q28476138-3B581158-A681-4AD3-AD99-44AC2D840019

P50

Q28476138-299A45DD-BD47-4C5F-803D-477DCA9E638D

Q28476138-807C10CF-B59F-49B2-9027-3F574D1BEC5D

Q28476138-940B7411-340B-4127-9DB8-A839AA45D03E

P577

Q28476138-0C54B774-DC1B-490D-909D-2847A4EE5EAC

P5875

Q28476138-C936FD00-4C3B-41F5-8B83-8612C72608E0

P698

Q28476138-ABB36A79-0B25-4CDD-8F8B-848CB6D9EB1F

P921

Q28476138-6FE9B824-CB97-45D4-9C32-F0489C9AEF01

P932

Q28476138-2DF8D60D-B48C-4C68-9FBF-0A8A48B50241

P3181

P356

JOURNAL.PONE.0007025

P1433

P1476

Identification of antifungal c ...... t Caenorhabditis elegans assay

@en

P2093

Andy Stern

http://www.w3.org/2001/XMLSchema#string

Annie L Conery

http://www.w3.org/2001/XMLSchema#string

Edward Holson

http://www.w3.org/2001/XMLSchema#string

Emmanouil Tampakakis

http://www.w3.org/2001/XMLSchema#string

Emmanouil Tempakakis

http://www.w3.org/2001/XMLSchema#string

Florence Wagner

http://www.w3.org/2001/XMLSchema#string

Gang Wu

http://www.w3.org/2001/XMLSchema#string

Ikechukwu Okoli

http://www.w3.org/2001/XMLSchema#string

Jonah Larkins-Ford

http://www.w3.org/2001/XMLSchema#string

W Frank An

http://www.w3.org/2001/XMLSchema#string

P2860

Keratitis due to Aspergillus flavus successfully treated with thiabendazole

The genetics of Caenorhabditis elegans

CellProfiler: image analysis software for identifying and quantifying cell phenotypes

A downstream target of RHO1 small GTP-binding protein is PKC1, a homolog of protein kinase C, which leads to activation of the MAP kinase cascade in Saccharomyces cerevisiae.

Rom2p, the Rho1 GTP/GDP exchange factor of Saccharomyces cerevisiae, can mediate stress responses via the Ras-cAMP pathway.

Target-oriented and diversity-oriented organic synthesis in drug discovery

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

CellProfiler: free, versatile software for automated biological image analysis

In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

P304

e7025

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3092055

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0007025

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Frederick M. Ausubel

Jeffrey J. Coleman

Eleftherios Mylonakis

P577

2009-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26808092

http://www.w3.org/2001/XMLSchema#string

P698

19750012

http://www.w3.org/2001/XMLSchema#string

P921

Caenorhabditis elegans

P932

2737148

http://www.w3.org/2001/XMLSchema#string